MicroCloud Hologram Inc. Files 2024 Annual Report on Form 20-F

MicroCloud Hologram Inc. Files 2024 Annual Report on Form 20-F

SHENZHEN, China, March 22, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (Nasdaq: HOLO) ("MicroCloud" or the "Company") today filed its operational and financial results for the fiscal year ended December 31, 2024, on Form 20-F with the U.S....

Zeekr Group Files Its 2024 Annual Report on Form 20-F

Zeekr Group Files Its 2024 Annual Report on Form 20-F

HANGZHOU, China, March 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it filed its 2024 annual report on...

Breakthrough Silane-Free Silicon Anode Patents for High Energy Lithium-ion Batteries

Breakthrough Silane-Free Silicon Anode Patents for High Energy Lithium-ion Batteries

Solidion files multiple patent applications on a new process to produce graphene ball-hosted silicon anode materials DALLAS, Feb. 11, 2025 /PRNewswire/ -- Solidion Technology, Inc. (NASDAQ: STI), an advanced battery technology solutions provider,...

Autozi Internet Technology (Global) Ltd. Announces Fiscal Year 2024 Financial Results and Files Its Annual Report on Form 20-F

Autozi Internet Technology (Global) Ltd. Announces Fiscal Year 2024 Financial Results and Files Its Annual Report on Form 20-F

BEIJING, Jan. 28, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. ("Autozi" or the "Company") (Nasdaq: AZI), one of the leading and fast-growing lifecycle automotive service providers in China, today announced its financial results for...

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.)...

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 The IND is a comprehensive dossier of information, including animal and human studies,...

Shawn "JAY-Z" Carter Files Motion Seeking Dismissal of Anonymous Lawsuit Or Disclosure of Plaintiff's Identity

Shawn "JAY-Z" Carter Files Motion Seeking Dismissal of Anonymous Lawsuit Or Disclosure of Plaintiff's Identity

NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Today, Shawn "JAY-Z" Carter filed a motion, seeking dismissal of the anonymous lawsuit submitted by attorney Tony Buzbee of the disclosure of the plaintiff's identity to remain anonymous. The filing from...

menu
menu